Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

Dana-Farber Cancer Institute · with National Cancer Institute (NCI), American Society of Clinical Oncology · NCT06469307

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
40
US sites recruiting
1
Study start
December 9, 2024
Record last updated
July 16, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this research study is to enhance inclusion and diversity in clinical trial enrollment by training participants to perform and provide feedback through a community-based protocol review process, called DIVERSE.

Being studied: DIVERSE Review Process

Conditions: Blood Cancer; Leukemia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

CAB Participant Inclusion Criteria

  • Age 18 or older
  • English speaking
  • Ability to understand and willingness to provide oral consent
  • DFCI patient who are in remission from a blood cancer >1 year will be preferred.

CAB Participant Exclusion Criteria

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers \<18 years old)
  • Prisoners.
  • Unwilling/unable to agree to maintaining the confidentiality of reviews and clinical trial materials, as outlined in Section 9.1
  • Note 1: Patients and non-patient community members who are pregnant are eligible. This is a non-interventional study that meets the definition of minimal risk and poses no greater risk to pregnant individuals or fetuses. Pregnancy status will not be assessed.
  • Note 2: English fluency is necessary as protocols being reviewed are written in English and cannot be feasibly translated to other languages within the time period necessary to complete timely reviews.

Investigator Participant Inclusion Criteria:

  • Age 18 older
  • English Speaking
  • Site or Principal investigator
  • Not a member of the research team

Recruiting US locations

  • Dana-Farber Cancer Institute

    Boston, MA 02215

    Site contact: Andrew Hantel, MD · 617-582-9394 · Andrew_Hantel@dfci.harvard.edu

Study contacts (from the official record)

  • Andrew Hantel, MD · 617-582-9394 · Andrew_Hantel@dfci.harvard.edu
  • Oldy S Bejarano, MPH · 857-215-2365 · oldy_bejarano@dfci.harvard.edu
All healthy volunteers studies in Massachusetts →
Driving Inclusivity, Validity, and Equity in Research Through… (NCT06469307) | Bored Studies